TALON CAPITAL CORP-CL A (TLNC:NASDAQ)
$10.2 -0.08 (-0.7782%)
Analysed TALON CAPITAL CORP-CL A (TLNC:NASDAQ) News Sources
Oricell Therapeutics Closes $110 Million Pre-IPO Financing to Accelerate Global Development of Solid Tumor CAR-T Therapies
10-04-2026
yahoo.com
Oricell Therapeutics Announces US$70M Initial Closing of Series C Financing, to Accelerate Global Development of Solid Tumor CAR-T Therapies
13-01-2026
yahoo.com
What is the current price of TALON CAPITAL CORP-CL A (TLNC:NASDAQ)?
The current price of TALON CAPITAL CORP-CL A (TLNC:NASDAQ) is $10.2.
TALON CAPITAL CORP-CL A (TLNC:NASDAQ) absolute price change since previous trading day?
The absolute price change of TALON CAPITAL CORP-CL A (TLNC:NASDAQ) since the previous trading day is $-0.08.
TALON CAPITAL CORP-CL A (TLNC:NASDAQ) percentage price change since previous trading day?
The percentage price change of TALON CAPITAL CORP-CL A (TLNC:NASDAQ) since the previous trading day is -0.7782%.
What is the most recent average sentiment score for TALON CAPITAL CORP-CL A (TLNC:NASDAQ)?
The most recent average sentiment score for TALON CAPITAL CORP-CL A (TLNC:NASDAQ) is 70 out of 100.
What is the most recent average sentiment for TALON CAPITAL CORP-CL A (TLNC:NASDAQ)?
The most recent sentiment for TALON CAPITAL CORP-CL A (TLNC:NASDAQ) is .
SEC-8K** Filing Available For TALON CAPITAL CORP-CL A (TLNC:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.